Fate Therapeutics
FATE
#8836
Rank
ยฃ0.16 B
Marketcap
ยฃ1.37
Share price
-0.81%
Change (1 day)
65.40%
Change (1 year)

Operating Margin for Fate Therapeutics (FATE)

Operating Margin as of November 2026 (TTM): -2,058.08%

According to Fate Therapeutics 's latest financial reports and stock price the company's current Operating Margin is -2,058.08%. At the end of 2021 the company had an Operating Margin of -379.89%.

Operating Margin history for Fate Therapeutics from 2013 to 2023

Operating Margin at the end of each year

Year Operating Margin Change
2021-379.89%-31.13%
2020-551.59%-38.89%
2019-902.59%-34.08%
2018-1,369.24%34.87%
2017-1,015.20%40.42%
2016-722.97%-36.72%
2015-1,142.41%
2013-2,069.82%301.86%
2012-515.06%-54.69%
2011-1,136.75%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
Becton Dickinson
BDX
7.17%-100.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
-6.63%-99.68%๐Ÿ‡บ๐Ÿ‡ธ USA
PTC Therapeutics
PTCT
-6.64%-99.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
24.66%-101.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNAM
-3,650.39% 77.37%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.